How has been the historical performance of the Ishita Drugs?
Ishita Drugs has shown mixed historical performance, with net sales slightly decreasing to Rs 15.00 crore in March 2025, but operating profit and profit after tax increased, reflecting improved profitability metrics. The company maintained a solid cash flow position despite fluctuations in sales.
Answer:The historical performance of Ishita Drugs shows a mixed trend in financial metrics over the years.Breakdown:
Ishita Drugs reported net sales of Rs 15.00 crore in March 2025, a slight decrease from Rs 15.19 crore in March 2024, but an increase from Rs 12.07 crore in March 2023. The total operating income mirrored this trend, reaching Rs 15.00 crore in March 2025. Raw material costs decreased to Rs 10.11 crore in March 2025 from Rs 11.37 crore in March 2024, while total expenditure (excluding depreciation) was Rs 14.00 crore in March 2025, down from Rs 14.28 crore in March 2024. Operating profit (PBDIT) increased to Rs 1.34 crore in March 2025, up from Rs 1.19 crore in March 2024, reflecting an operating profit margin of 6.67%. Profit before tax also rose to Rs 1.16 crore in March 2025 from Rs 0.99 crore in March 2024, leading to a profit after tax of Rs 0.87 crore in March 2025, compared to Rs 0.75 crore in March 2024. The earnings per share (EPS) improved to Rs 2.91 in March 2025 from Rs 2.51 in March 2024. On the balance sheet, total assets were Rs 10.81 crore in March 2024, slightly down from Rs 11.41 crore in March 2023, while total liabilities decreased to Rs 10.81 crore in March 2024 from Rs 11.41 crore in March 2023. Cash flow from operating activities was Rs 2.00 crore in March 2024, indicating a positive cash position. Overall, while there were fluctuations in sales and profits, the company demonstrated resilience with a steady increase in profitability metrics and a solid cash flow position.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
